CAS 248260-75-5 appears in our catalog under these names: KRN2, 13-((2-Fluorophenyl)methyl)-5,6-dihydro-9,10-dimethoxy-benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium chloride, KRN2, 98.04%. Offered by: GLPBio, TargetMol, Biosynth, MedChemExpress. Available pack sizes: 5mg, 25mg, 50mg, 100mg, 10mg, 10 mg, 100 mg, 50 mg.
KRN2 is a selective inhibitor of nuclear factor of activated T cells (NFAT5), with an IC50 of 100 nM. KRN2 has potential to treat NFAT5-mediated Chronic Arthritis.
Source: ChEBI
| Molecular formula | C27H23ClFNO4 |
|---|---|
| Molecular weight | 479.9 g/mol |
| IUPAC name | 21-[(2-fluorophenyl)methyl]-16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene chloride |
| InChIKey | RPHFGOXVJGNJJH-UHFFFAOYSA-M |
| SMILES | COC1=C(C2=C[N+]3=C(C4=CC5=C(C=C4CC3)OCO5)C(=C2C=C1)CC6=CC=CC=C6F)OC.[Cl-] |
Computed by PubChem (NCBI)